Phase II study of vinorelbine (NVB) and UFT in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.

被引：0
|
作者：
Anton, A
Puertolas, T
Ramos, M
Barnadas, A
Florian, J
Grande, R
Ribelles, N
Lomas, M
机构：
[1] Hosp Miguel Servet, Zaragoza, Spain
[2] Ctr Oncol, Coruna, Spain
[3] Hosp Germans Trias & Pujol, Badalona, Spain
[4] Hosp Barbastro, Huesca, Spain
[5] Hosp Virgen Victoria, Malaga, Spain
[6] Hosp Infanta Cristina, Badajoz, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
751
引用
收藏
页码：64S / 64S
页数：1
相关论文
共 50 条
  • [11] Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes
    Jones, Alison
    O'Brien, Mary
    Sommer, Harald
    Nowara, Elzbieta
    Welt, Anja
    Pienkowski, Tadeusz
    Rolski, Janusz
    Pham, My-Linh
    Perraud, Kevin
    Trillet-Lenoir, Veronique
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (04) : 755 - 763
  • [12] A phase II study of capecitabine and vinorelbine in patients with metastatic breast cancer pretreated with anthracyclines and taxanes
    Estevez, Laura G.
    Batista, Norberto
    Sanchez-Rovira, Pedro
    Velasco, Amalia
    Provencio, Mariano
    Leon, Ana
    Domine, Manuel
    Cruz, Josefina
    Rodriguez, Milva
    CLINICAL BREAST CANCER, 2008, 8 (02) : 149 - 154
  • [13] A phase I/II study of bortezomib and capecitabine in patients with metastatic breast cancer previously treated with taxanes and/or anthracyclines
    Schmid, P.
    Kuehnhardt, D.
    Kiewe, P.
    Lehenbauer-Dehm, S.
    Schippinger, W.
    Greil, R.
    Lange, W.
    Preiss, J.
    Niederle, N.
    Brossart, P.
    Freier, W.
    Kuemmel, S.
    de Velde, H. Van
    Regierer, A.
    Possinger, K.
    ANNALS OF ONCOLOGY, 2008, 19 (05) : 871 - 876
  • [14] Biweekly vinorelbine and tegafur/uracil in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: GEICAM 2000-02 phase II study
    Anton, Antonio
    Barnadas, Agusti
    Florian, Jesus
    Ribelles, Nuria
    Lomas, Maria
    Lao, Juan
    Gonzalez-Quintas, Ana
    Margeli, Mireia
    Paules, Ana Belen
    Gayo, Javier
    Ramos, Manuel
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (04): : 281 - 286
  • [15] A phase I study of an all-oral combination of vinorelbine/capecitabine in patients with metastatic breast cancer previously treated with anthracyclines and/or taxanes
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Sunela, Kaisa
    Lehtinen, Ilari
    Joensuu, Heikki
    Sjostrom-Mattson, Johanna
    CLINICAL BREAST CANCER, 2006, 7 (05) : 401 - 405
  • [16] A phase 2 study of oxaliplatin (O) - capecitabine (C) chemotherapy in metastatic breast cancer (MBC) patients pretreated with anthracyclines and taxanes.
    Gebbia, N
    Fulfaro, F
    Badalamenti, G
    Arcara, C
    Cicero, G
    Rinaldi, G
    Vizzini, L
    Spinnato, F
    Russo, A
    Valerio, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 53S - 53S
  • [17] A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study
    Yalcin, Bulent
    Uner, Aytug
    Akbulut, Hakan
    Icli, Fikri
    Buyukcelik, Abdullah
    Isikdogan, Abdurrahman
    Dincol, Dilek
    Demirkazik, Ahmet
    Onur, Handan
    Bozcuk, Hakan
    ANNALS OF ONCOLOGY, 2004, 15 : 42 - 42
  • [18] Late phase II clinical study of vinorelbine monotherapy in advanced or recurrent breast cancer previously treated with anthracyclines and taxanes
    Toi, M
    Saeki, T
    Aogi, K
    Sano, M
    Hatake, K
    Asaga, T
    Tokuda, Y
    Mitsuyama, S
    Kimura, M
    Kobayashi, T
    Tamura, M
    Tabei, T
    Shin, E
    Nishimura, R
    Ohno, S
    Takashima, S
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2005, 35 (06) : 310 - 315
  • [19] Vinorelbine and cisplatin in metastatic breast cancer patients previously treated with anthracyclines
    Vassilomanolakis, M
    Koumakis, G
    Barbounis, V
    Demiri, M
    Pateras, H
    Efremidis, AP
    ANNALS OF ONCOLOGY, 2000, 11 (09) : 1155 - 1160
  • [20] A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines
    George Orphanos
    Athanasios Alexopoulos
    Savvoula Malliou
    George Ioannidis
    Alexandros Ardavanis
    Constantinos Kandylis
    John Stavrakakis
    Gerassimos Rigatos
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 115 - 121
12345